Conferences and Meetings on Immunology and allergic diseases

Submit a meeting

Select a location:
Austria (1) - Canada (3) - Germany (1) - India (1) - Iran (1) - Israel (1) - Italy (2) - Russia (1) - Spain (1) - Sri Lanka (1) - United States (7)

ALL COUNTRIES

1
INDIA DIAGNOSTIC EXPO 2017
08 Dec 2017 - 10 Dec 2017 • Hyderabad, India
Contact:
Karuna Vaid;     Phone: [+91-9811461158];     Email: indiadiagnosticexpohyd@gmail.com
Event listing ID:
932188
Related subject(s):
2
Gordon Research Conference — Food Allergy
07 Jan 2018 - 12 Jan 2018 • Ventura, CA, United States
Topics:
Mechanisms, Prevention of, and Emerging Therapies for Food Allergy
Event listing ID:
960251
Related subject(s):
3
Keystone Symposia: Emerging Technologies in Vaccine Discovery and Development
28 Jan 2018 - 01 Feb 2018 • Banff, Alberta, Canada
Abstract:
Immunization remains one of the most effective preventive public health measures, the indirect effects of which are considered a global public good with an impressive net return over costs. Vaccines have contributed to “final public good”: eradication of two viruses and regional elimination of a half dozen or more other pathogens. The development of new vaccines, therefore, would seem an obvious priority area for use-inspired and applied biomedical research, yet the endeavor has become increasingly more challenging. The “easy vaccines have been made” belief, crowded vaccine schedules, escalating costs of full vaccination programs (particularly in cost-sensitive Gavi-eligible countries), and platforms for maternal immunization and Public Health Emergencies of International Concern have all contributed to an urgent need for new or improved approaches to the discovery, development and delivery of vaccines, particularly those that are cheaper, simpler to manufacture, and more convenient to use. The aim of this symposium is to provide a comprehensive survey of emerging tools from the most upstream antigen/vaccine discovery, to active and passive immunization platforms, clinical trials, and manufacturing, formulation and delivery, the desired outcome of which is to provide a forum for an integrated discussion on how best to meet the increasing challenges faced by the scientific community’s efforts in new vaccine development. The Keystone Symposia conference has been specifically paired with the conference on “HIV Vaccines” since discovering, developing and delivering an effective HIV vaccine may be one that benefits most from novel technologies, including new tools in structural immunology and interrogating human immune responses.
Contact:
Attendee Services;     Phone: [970.262.1230 or 800.253.0685];     Email: info@keystonesymposia.org
Topics:
vaccine development, public health, structural immunology, novel technologies
Event listing ID:
926155
4
Keystone Symposia: Progress and Pathways Toward an Effective HIV Vaccine
28 Jan 2018 - 01 Feb 2018 • Banff, Canada
Abstract:
After three decades, HIV-1 continues to afflict and kill millions of people worldwide. A safe and effective vaccine that elicits potent and durable protective immunity has the greatest prospect to end the AIDS epidemic. Development of an HIV vaccine has proven scientifically challenging, as evidenced by only one weakly efficacious regimen after evaluation of four distinct regimens. However, the field is in a phase of rapid growth and innovation for new vaccine strategies that hold promise for efficacy. Such emerging, novel findings will be the focus of this meeting, and will include: 1) Technological advances in structural properties of the HIV-1 envelope glycoprotein and its recognition and interactions with potent neutralizing antibodies; 2) Improved animal model platforms that can better mimic the transmitted founder HIV-1 strains and human immune recognition; 3) Greater understanding of host B and T cell immunobiology in the lymphoid germinal centers that is critical to optimize candidate vaccines and immunization regimens; 4) New tools for interrogating human immune repertoire; and 5) highlights of promising strategies in first in human to efficacy studies. Emphasis will be placed on unpublished findings and advances specifically relevant to human immunology and HIV vaccine targets. This meeting is being paired with the Keystone Symposia conference on "Emerging Technologies in Vaccine Discovery and Development."
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
Drug discovery, antibodies, immunology, HIV, biologics, infectious disease, AIDs
Event listing ID:
948153
5
Keystone Symposia: Translational Systems Immunology
28 Jan 2018 - 01 Feb 2018 • Snowbird, Utah, United States
Abstract:
This conference will cover the exciting technology advances that are enhancing our ability to elucidate human immune function and networks as well as practical applications in drug and biomarker discovery and patient stratification. The meeting begins with a look at progress in human genetics and the use of sequencing to assign functional mutations to rare human immune phenotypes. The impact of common variants on immune function requires larger sample sizes, and speakers will cover how genome-wide high-throughput genomics in combination with detailed phenotyping and physiologically relevant perturbations are providing foundational data sets that allow an unbiased view of immune function in cells and tissues. Also discussed will be emerging computational and analytical methods that enable integration and interpretation of high-content molecular data. The meeting will then move on to look at the application of these technological advances, expanding investigation to study the immune response in tissues and organs to enable a deeper understanding of interaction between immune and non-immune cells and their respective roles in disease states. Critical to clinical progress is the translation of systems immunology research into novel therapies and diagnostic or prognostic tests. Sessions themed around infectious disease and vaccine development advances in immune-oncology and patient stratification in complex disease and treatment response aim to provide depth from foundational science to clinical translation. Finally, a key goal is fostering collaboration across disciplines and the development of novel ideas. The meeting will be relevant for immunologists, computational biologists and clinicians with an interest in molecular characterization of the immune system.
Contact:
Attendee Services;     Phone: [970.262.1230 or 800.253.0685];     Email: info@keystonesymposia.org
Topics:
immune-oncology, genomics, physiology, vaccine development, infectious diseases, translational medicine
Event listing ID:
926102
Related subject(s):
6
Cell-Weizmann Institute of Science Symposium: Next Gen Immunology
11 Feb 2018 - 14 Feb 2018 • Rehovot, Israel
Abstract:
To help to address this challenge, the Cell-Weizmann Institute of Science Symposium: Next Gen Immunology is bringing together leading scientists who think about immunity in different contexts and have in common the perspective of an immune system that is an integral part of the meta-organism. They are also driving the development of new tools that are much needed to understand the functional diversity of the immune response: from live in vivo imaging and single-cell technologies, to ‘omics’ approaches.
Event listing ID:
923938
7
Keystone Symposia - Phosphoinositide Biology: New Therapeutic Targets Beyond Class I PI3K
11 Feb 2018 - 15 Feb 2018 • Taos, New Mexico, United States
Abstract:
Phosphoinositides have been recognized since the 1980s as important regulatory lipids supporting signal transduction from G protein-coupled receptors and receptor tyrosine kinases. The discovery of PI 3-kinases and their roles in carcinogenesis and immune regulation has created a fertile ground for translational expansion of the phosphoinositide field with a focus on cancer and inflammation. Most of these advances focused on Class I PI3Ks and PIP3-mediated signaling. However, research on other PI kinases and phosphoinositides has expanded substantially over the years. Class II and -III PI 3-kinases and less characterized 3-phosphorylated phosphoinositides are now rapidly emerging as key controllers of development, trafficking, nutrition-sensing and autophagy. Furthermore, phosphoinositides different from the 3-phosphorylated species are gaining momentum in many aspects of cell physiology and pathology. Exciting new developments include PI 4-kinases controlling vesicular trafficking and non-vesicular lipid transfer between membrane contacts, and new details are emerging on the role of inositol lipid phosphatases in trafficking, endocytosis and ciliary function. The recently recognized roles of PI 4-kinases as obligate host factors for certain RNA viruses, and their importance in parasitic organisms such as Plasmodium falciparum or Legionella pneumophila, have raised significant interest from pharmaceutical companies that now focus on inositol lipids other than the products of PI 3-kinases. By expanding our knowledge of phosphoinositides beyond class I PI3K products, this Keystone Symposia meeting represents a unique opportunity to bolster the rising interest in these under-explored avenues with a strong potential for translational impact.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
development, drug discovery, cancer, infectious disease, cell signaling, genetics, cell physiology
Event listing ID:
948464
8
Keystone Symposia - Emerging Cellular Therapies: T Cells and Beyond
11 Feb 2018 - 15 Feb 2018 • Keystone, Colorado, United States
Abstract:
A new community of researchers is emerging that focuses on studying and developing cellular therapies against cancer and chronic infections. The field is advancing rapidly due to our deepening understanding of cell biology. New technologies permit efficient cell culture, gene transfer and genetic editing, enabling autologous and allogeneic cell therapy. With rapid development of CAR T cells, breakthrough FDA approval status, and fast-tracking clinical trials, competition is fierce in the biotechnology and pharmaceutical industries. Cell therapies with stem cells and T cells are in advanced clinical development that will enable widespread use for cancer and chronic infections such as HIV. Infusions of regulatory T cells (Tregs) have the potential to benefit patients with autoimmunity and transplantation. A goal of this conference is to bring together basic and translational scientists from these fields to identify current opportunities and challenges in cell therapies. Another goal is to bridge the fields of effector T cell and Treg cell therapies. The interdisciplinary features of this meeting should facilitate new collaborations and interactions between investigators who would not normally meet. This meeting is paired with the Keystone Symposia conference on "Lymphocytes and their Roles in Cancer."
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
T cell and B cell biology, cancer, genetics, genomics, drug discovery, infectious disease, HIV, translational medicine, stem cells
Event listing ID:
948529
Related subject(s):
9
Keystone Symposia: Lymphocytes and their Roles in Cancer
11 Feb 2018 - 15 Feb 2018 • Keystone, Colorado, United States
Abstract:
Leverage of the body’s own immune system is revolutionizing the way that we treat cancer as it can lead to dramatic and durable responses. Such anti-tumor therapies include reactivation of anti-tumor T cells, expansion of tumor-infiltrating lymphocytes (TILs), Chimeric antigen receptor (CAR) T cells and a variety of cancer vaccines. The focus or target of most these approaches are cells of the lymphocytic lineage (T, B, NK, dendritic cells), key components of both adaptive and innate immune response. At the same time, lymphocytes can also be malignant, as in the case of a large number of lymphocytic leukemia and lymphoma subtypes, and active components of the immune microenvironment, controlling tumor growth and anti-tumor response. This conference for the first time brings together scientists from these different areas of lymphocyte biology and provides an overview of lymphocyte development, transformation, terminal differentiation, location within the tumor microenvironment and anti-tumor activity. The conference also provides an update on novel therapy protocols that attempt to harness the function of lymphocytes against cancer and state-of-the-art technologies, including imaging and DNA/RNA sequencing approaches, that will help us visualize and molecularly dissect anti-tumor responses in experimental systems and cancer patients.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
cancer, immunology, drug discovery, technologies, T cell biology, genetics, genomics
Event listing ID:
948559
Related subject(s):
10
Keystone Symposia: Regulation and Dysregulation of Innate Immunity in Disease
18 Feb 2018 - 22 Feb 2018 • Vancouver, British Columbia, Canada
Abstract:
The innate immune system is fundamental to protect us from pathogens. Although the core components were first elucidated in model organisms such as Drosophila and mice, exactly how they are regulated in human health and contribute to disease remains to be fully defined. Over the past several years, our ability to study the innate immune response has been enabled by a number of transformative tools that can be used to assess gene expression, cellular physiology and gene function. Such technological advances have begun to reveal new components of the innate immune system and have led to a better understanding of its regulation and dysregulation. Importantly, these new insights have allowed us to better understand the pathophysiological basis of certain human diseases and to identify new therapeutic targets to alleviate them. This conference aims to gather different view-points on the field of innate immunity to discuss advances in signaling and regulatory networks and to understand how their dysregulation contributes to immunopathologies and auto-inflammatory conditions.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
innate immunity, immunology
Event listing ID:
963941
11
Health Conf 2018 — The International Conference on Public Health
22 Mar 2018 • Colombo, Sri Lanka
Abstract:
International Conference on Public Health 2018 (Health Conf 2018) will be held on 22nd and 23rd March 2018 in Colombo, Sri Lanka. You are kindly invited to send your abstracts and research papers for The International Conference on Public Health 2018 (Health Conf 2018). In International Conference on Public Health enriched with a diversity of plenaries from world leaders, oral papers, panels, workshops, and posters showcasing new learning and researchers about public health from all over the world. “Health Conf 2018” is a great platform to learn, review and reflect on the continuing challenges of enhancing health.
Contact:
Rekheetha Pathiranage;     Phone: [0094772241493];     Email: publichealthconference2018@gmail.com
Topics:
Accessibility to healthcare, Community Health, Disaster and Public Health, Environmental Public Health Educational and Community-Based Programs, Oral Health, Information Technology and Public Health Health communications, Healthcare costs, Health Economics Health Education, Breast and pelvic examinations, Breast and cervical cancer screening Family Planning, Maternal, Infant, and Child Health, Mental Health and Mental Disorders Occupational Safety and HealthSexually Transmitted Diseases, Urban Public Health, Public Health Nutrition, Social Determinants of Health
Event listing ID:
958846
12
Gordon Research Seminar — Antibody Biology and Engineering
24 Mar 2018 - 25 Mar 2018 • Lucca (Barga) , Italy
Topics:
Manipulating the Immune System with Natural and Synthetic Antibodies
Event listing ID:
961071
Related subject(s):
13
Gordon Research Conference — Antibody Biology and Engineering
25 Mar 2018 - 30 Mar 2018 • Lucca (Barga) , Italy
Topics:
Antibodies as Change Agents – Biological Diversity and Synergies
Event listing ID:
961072
Related subject(s):
14
EECAAC 2018 — VI Eastern Europe and Central Asia AIDS Conference
18 Apr 2018 - 20 Apr 2018 • Moscow, Russia
Abstract:
The Russian Government recognizes the importance of national HIV/AIDS response and considers EECAAC 2018 a unique opportunity to coordinate the efforts of the countries in combating the epidemic through the discussion and development of new approaches in prevention and treatment.
Event listing ID:
937725
Related subject(s):
Event website:
15
14th International Congress of Immunology and Allergy
26 Apr 2018 - 29 Apr 2018 • Tehran, Iran
Abstract:
On behalf of the  Iranian Society for Immunology and Allergy (ISIA)  we are very proud to host the  14th International Congress of Immunology and Allergy (14 th  ICIA)  in Tehran, from April 26-29, 2018. We welcome all of you from every part of the world to discuss and learn about the latest research and advancements and collaborate with colleagues. The meeting will focus on major breakthroughs and advances in Immunology and Allergy, ranging from clinical practice to research, technology and innovation. Outstanding immunologist from around the world will play a vital role in every  14 th  ICIA  session.
Event listing ID:
956406
Event website:
16
45th European Calcified Tissue Society Congress
26 May 2018 - 29 May 2018 • Valencia, Spain
Abstract:
With an international delegation of clinicians and basic scientists, ECTS Congress is the meeting where great science, collaboration and research across the musculoskeletal field come together. By submitting an abstract you can become an active part of the congress and have the opportunity to share and discuss your work with other experts in the field. This year, ECTS 2018 will feature more opportunities for focused poster presentations to create networks and exchange ideas.
Contact:
Severine Weinz;     Phone: [+49 40 32 50 92 57];     Email: s.weinz@interplan.de
Topics:
Biochemistry, cell & molecular; Biomechanics; Bone; Cancer; Endocrinology; Genetics; Kidney Disease; Orthopaedics; Pharmacology; Rheumatology
Event listing ID:
955932
Event website:
17
Gordon Research Seminar — Immunochemistry and Immunobiology
09 Jun 2018 - 10 Jun 2018 • Mount Snow, West Dover, VT, United States
Topics:
Engineering the Immune System: Applications in Clinical and Technological Translation
Event listing ID:
960598
18
Gordon Research Conference — Immunochemistry and Immunobiology
10 Jun 2018 - 15 Jun 2018 • Mount Snow, West Dover, VT, United States
Topics:
Advances in Immunology and Immunotechnology: Insights in the Regulation of Protective and Pathological Immune Responses
Event listing ID:
960544
19
EMBO|EMBL Symposium: Innate Immunity in Host-Pathogen Interactions
24 Jun 2018 - 27 Jun 2018 • Heidelberg, Germany
Abstract:
This symposium will build on the first meeting which took place in 2016. Microbiologists and immunologists will again come together to provide different viewpoints on the same problems in joint sessions. While maintaining continuity in topics, the meeting concept will be evolved by introducing novel sessions on bacterial defenses against innate immunity, an area prominently covered by abstract submissions in the 2016 meeting, and on fungus host interactions, an under-researched area of great medical importance.
Contact:
EMBL CCO;     Email: events@embl.de
Topics:
Microbiology, Immunology
Event listing ID:
935852
Related subject(s):
20
immunology — Immunology 2018 (CPD accredited)
05 Jul 2018 - 07 Jul 2018 • Vienna, Austria
Abstract:
The EuroSciCon will be holding its CPD accredited for Immunology conference on July 05 - 07, 2018 Vienna, Austria.
Contact:
Sara Wallner;     Phone: [02038073712];     Email: immunology@eurosciconconferences.com
Topics:
Antibody, Inflammation, Biomarkers, Receptors, Transplantation, Immunological techniques
Event listing ID:
918701


Conference-Service.com offers, as part of its business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Last updated: 01 November 2017